Simulation of heterogeneous molecular delivery in tumours using μCT reconstructions and MRI validation

Alic, 2011, Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response?, Phys. Med. Biol., 56, 1601, 10.1088/0031-9155/56/6/006 Atwood, 2010, Quantitation of microcomputed tomography-imaged ocular microvasculature, Microcirculation, 17, 59, 10.1111/j.1549-8719.2009.00009.x Bentzen, 2005, Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor, Int. J. Radiat. Oncol. Biol. Phys., 61, 1208, 10.1016/j.ijrobp.2004.12.020 Bolland, 2008, Development of in vivo muCT evaluation of neovascularisation in tissue engineered bone constructs, Bone, 43, 195, 10.1016/j.bone.2008.02.013 Carmeliet, 2000, Angiogenesis in cancer and other diseases, Nature, 407, 249, 10.1038/35025220 Chen, 2005, Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant, Magn. Reson. Imaging, 23, 685, 10.1016/j.mri.2005.02.015 Downey, 2012, Quantitative ex-vivo micro-computed tomographic imaging of blood vessels and necrotic regions within tumors, PLoS One, 7, 10.1371/journal.pone.0041685 Furman-Haran, 1997, Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors, J. Magn. Reson., 128, 161, 10.1006/jmre.1997.1220 Gordon, 1999, Measurement of Gd-DTPA diffusion through PVA hydrogel using a novel magnetic resonance imaging method, Biotechnol. Bioeng., 65, 459, 10.1002/(SICI)1097-0290(19991120)65:4<459::AID-BIT10>3.0.CO;2-O Horsman, 2003, Erythropoietin improves the oxygen carrying capacity of mouse blood without changing hypoxia in a murine tumour model, Eur. J. Cancer Junttila, 2013, Influence of tumour micro-environment heterogeneity on therapeutic response, Nature, 501, 346, 10.1038/nature12626 Miles, 1991, Colour perfusion imaging: a new application of computed tomography, Lancet, 337, 643, 10.1016/0140-6736(91)92455-B Mor-Avi, 1993, Myocardial regional blood flow: quantitative measurement by computer analysis of contrast enhanced echocardiographic images, Ultrasound Med. Biol., 19, 619, 10.1016/0301-5629(93)90069-Z Nielsen, 2008, Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients, Int. J. Radiat. Oncol. Biol. Phys., 70, 859, 10.1016/j.ijrobp.2007.10.012 Nielsen, 2012, Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in preclinical studies of antivascular treatments, Pharmaceutics, 4, 563, 10.3390/pharmaceutics4040563 Overgaard, 1980, Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo, Int. J. Radiat. Oncol. Biol. Phys., 6, 1507, 10.1016/0360-3016(80)90008-5 Padhani, 2002, Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions, J. Magn. Reson. Imaging, 16, 407, 10.1002/jmri.10176 Tofts, 1997, Modeling tracer kinetics in dynamic Gd-DTPA MR imaging, J. Magn. Reson. Imaging, 7, 91, 10.1002/jmri.1880070113 Tofts, 1999, Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols, J. Magn. Reson. Imaging, 10, 223, 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S Wittenborn, 2012, Ultrahigh-field DCE-MRI of angiogenesis in a novel angiogenesis mouse model, J. Magn. Reson. Imaging, 35, 703, 10.1002/jmri.22855 Wittenborn, 2014, Accumulation of nano-sized particles in a murine model of angiogenesis, Biochem. Biophys. Res. Commun., 443, 470, 10.1016/j.bbrc.2013.11.127 Zienkiewicz, 2005